![Caroline Litchfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Litchfield
Director of Finance/CFO at
IMMUNE DESIGN CORP
Net worth: 11 M $ as of 28/02/2026
Profile
Ms. Caroline A. Litchfield is a Chief Financial Officer & Director at Immune Design Corp. and a Chief Financial Officer & Executive Vice President at Merck & Co., Inc. She is on the Board of Directors at Immune Design Corp. Ms. Litchfield was previously employed as a Finance Director by Merck Sharp & Dohme Ltd. She received her undergraduate degree from the University of Leicester.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/02/2026 | 90,192 ( 0% ) | 11 M $ | 28/02/2026 |
Caroline Litchfield active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNE DESIGN CORP | Director of Finance/CFO | - |
| MERCK & CO., INC. | Director of Finance/CFO | 01/04/2021 |
| VERIZON COMMUNICATIONS, INC. | Director/Board Member | 01/10/2024 |
Former positions of Caroline Litchfield
| Companies | Position | End |
|---|---|---|
| ORGANON & CO. | Director/Board Member | 31/05/2021 |
| FULFORD (INDIA) LIMITED | Director/Board Member | 30/01/2014 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Director of Finance/CFO | 23/06/2009 |
Training of Caroline Litchfield
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Verizon Communications, Inc.
 Verizon Communications, Inc. Wireless TelecommunicationsCommunications Operates as a holding company whose subsidiaries provides wireless and wire line communications services and products | Communications |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
University of Leicester
 University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Organon & Co.
 Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
- Stock Market
- Insiders
- Caroline Litchfield
